These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34536819)

  • 41. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies.
    Fiock KL; Betters RK; Hefti MM
    J Histochem Cytochem; 2023 Feb; 71(2):73-86. PubMed ID: 36861683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.
    Yamazaki M; Hasegawa M; Mori O; Murayama S; Tsuchiya K; Ikeda K; Chen KM; Katayama Y; Oyanagi K
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):839-46. PubMed ID: 16215455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.
    Buée L; Delacourte A
    Brain Pathol; 1999 Oct; 9(4):681-93. PubMed ID: 10517507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Hart de Ruyter FJ; Morrema THJ; den Haan J; ; Twisk JWR; de Boer JF; Scheltens P; Boon BDC; Thal DR; Rozemuller AJ; Verbraak FD; Bouwman FH; Hoozemans JJM
    Acta Neuropathol; 2023 Feb; 145(2):197-218. PubMed ID: 36480077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-based classification of tauopathies.
    Shi Y; Zhang W; Yang Y; Murzin AG; Falcon B; Kotecha A; van Beers M; Tarutani A; Kametani F; Garringer HJ; Vidal R; Hallinan GI; Lashley T; Saito Y; Murayama S; Yoshida M; Tanaka H; Kakita A; Ikeuchi T; Robinson AC; Mann DMA; Kovacs GG; Revesz T; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
    Nature; 2021 Oct; 598(7880):359-363. PubMed ID: 34588692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic Architecture of Primary Tauopathies.
    Gallo D; Ruiz A; Sánchez-Juan P
    Neuroscience; 2023 May; 518():27-37. PubMed ID: 35609758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites.
    Paterno G; Torrellas J; Bell BM; Gorion KM; Quintin SS; Hery GP; Prokop S; Giasson BI
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. αB-crystallin and HSP27 in glial cells in tauopathies.
    López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I
    Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
    Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
    Nogami A; Yamazaki M; Saito Y; Hatsuta H; Sakiyama Y; Takao M; Kimura K; Murayama S
    J Nippon Med Sch; 2015; 82(6):266-73. PubMed ID: 26823029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
    Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
    Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
    Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
    Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
    Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.